270 related articles for article (PubMed ID: 23092290)
1. The effects of β-glucans on dendritic cells and implications for cancer therapy.
Albeituni SH; Yan J
Anticancer Agents Med Chem; 2013 Jun; 13(5):689-98. PubMed ID: 23092290
[TBL] [Abstract][Full Text] [Related]
2. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.
Qi C; Cai Y; Gunn L; Ding C; Li B; Kloecker G; Qian K; Vasilakos J; Saijo S; Iwakura Y; Yannelli JR; Yan J
Blood; 2011 Jun; 117(25):6825-36. PubMed ID: 21531981
[TBL] [Abstract][Full Text] [Related]
3. Effects of beta-glucans on the immune system.
Akramiene D; Kondrotas A; Didziapetriene J; Kevelaitis E
Medicina (Kaunas); 2007; 43(8):597-606. PubMed ID: 17895634
[TBL] [Abstract][Full Text] [Related]
4. Cell type-specific differences in β-glucan recognition and signalling in porcine innate immune cells.
Baert K; Sonck E; Goddeeris BM; Devriendt B; Cox E
Dev Comp Immunol; 2015 Jan; 48(1):192-203. PubMed ID: 25453580
[TBL] [Abstract][Full Text] [Related]
5. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
[TBL] [Abstract][Full Text] [Related]
6. Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer.
Li B; Cai Y; Qi C; Hansen R; Ding C; Mitchell TC; Yan J
Clin Cancer Res; 2010 Nov; 16(21):5153-64. PubMed ID: 20855461
[TBL] [Abstract][Full Text] [Related]
7. Innate immunity induced by fungal β-glucans via dectin-1 signaling pathway.
Lee DH; Kim HW
Int J Med Mushrooms; 2014; 16(1):1-16. PubMed ID: 24940900
[TBL] [Abstract][Full Text] [Related]
8. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models.
Hong F; Yan J; Baran JT; Allendorf DJ; Hansen RD; Ostroff GR; Xing PX; Cheung NK; Ross GD
J Immunol; 2004 Jul; 173(2):797-806. PubMed ID: 15240666
[TBL] [Abstract][Full Text] [Related]
9. Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway.
Li B; Allendorf DJ; Hansen R; Marroquin J; Ding C; Cramer DE; Yan J
J Immunol; 2006 Aug; 177(3):1661-9. PubMed ID: 16849475
[TBL] [Abstract][Full Text] [Related]
10. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.
Vetvicka V; Thornton BP; Ross GD
J Clin Invest; 1996 Jul; 98(1):50-61. PubMed ID: 8690804
[TBL] [Abstract][Full Text] [Related]
11. The effects of β-glucans on cancer metastasis.
Yoon TJ; Koppula S; Lee KH
Anticancer Agents Med Chem; 2013 Jun; 13(5):699-708. PubMed ID: 23140352
[TBL] [Abstract][Full Text] [Related]
12. β-Glucan enhances cytotoxic T lymphocyte responses by activation of human monocyte-derived dendritic cells via the PI3K/AKT pathway.
Ding J; Feng T; Ning Y; Li W; Wu Q; Qian K; Wang Y; Qi C
Hum Immunol; 2015 Mar; 76(2-3):146-54. PubMed ID: 25636576
[TBL] [Abstract][Full Text] [Related]
13. The effects of beta-glucan on human immune and cancer cells.
Chan GC; Chan WK; Sze DM
J Hematol Oncol; 2009 Jun; 2():25. PubMed ID: 19515245
[TBL] [Abstract][Full Text] [Related]
14. β-Glucans and their applications in cancer therapy: focus on human studies.
Aleem E
Anticancer Agents Med Chem; 2013 Jun; 13(5):709-19. PubMed ID: 23140353
[TBL] [Abstract][Full Text] [Related]
15. Medicinal importance of fungal beta-(1-->3), (1-->6)-glucans.
Chen J; Seviour R
Mycol Res; 2007 Jun; 111(Pt 6):635-52. PubMed ID: 17590323
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory effects of beta-glucans on porcine alveolar macrophages and bone marrow haematopoietic cell-derived dendritic cells.
Chaung HC; Huang TC; Yu JH; Wu ML; Chung WB
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):147-57. PubMed ID: 19410299
[TBL] [Abstract][Full Text] [Related]
17. A (1→6)-Branched (1→4)-β-d-Glucan from
Su CH; Lu MK; Lu TJ; Lai MN; Ng LT
J Nat Prod; 2020 Feb; 83(2):231-242. PubMed ID: 31967822
[TBL] [Abstract][Full Text] [Related]
18. Fungal β-glucan, a Dectin-1 ligand, promotes protection from type 1 diabetes by inducing regulatory innate immune response.
Karumuthil-Melethil S; Gudi R; Johnson BM; Perez N; Vasu C
J Immunol; 2014 Oct; 193(7):3308-21. PubMed ID: 25143443
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor monoclonal antibodies in conjunction with β-glucans: a novel anti-cancer immunotherapy.
Xiang D; Sharma VR; Freter CE; Yan J
Curr Med Chem; 2012; 19(25):4298-305. PubMed ID: 22834812
[TBL] [Abstract][Full Text] [Related]
20. The application of fungal β-glucans for the treatment of colon cancer.
Chen J; Zhang XD; Jiang Z
Anticancer Agents Med Chem; 2013 Jun; 13(5):725-30. PubMed ID: 23293888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
